Galecto (GLTO) Stock: Buy, Sell, or Hold?
$28.69
-0.22 (-0.76%)
âŧ
5d:
-4.53%
30d:
+26.78%
90d:
+29.5%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (67%)
Quality Score
45/100
Position
FAIR
Forward P/E & Valuation
-18.4x
Next 12M consensus est.
Wall Street Target
$32.00
+11.5% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$27.10 / $33.99
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: GLTO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When GLTO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: GLTO is currently trading at $28.69, which is considered fair based on recent price action.
Technical Outlook: Technically, GLTO is in a strong uptrend. Immediate support is located at $27.10, while resistance sits at $33.99.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $32.00 (+11.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GLTO is in a strong uptrend. Immediate support is located at $27.10, while resistance sits at $33.99.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $32.00 (+11.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
45/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
66.8%
Trading Range & Key Levels
Support Level
$27.10
Resistance Level
$33.99
Current Trend
Strong Uptrend
Technical data as of
Mar 9, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: Trading below Wall St target ($32.00)
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-18.39
Wall Street Target
$32.00
(+11.5%)
Share GLTO Analysis
Share this live GLTO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (GLTO)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Feb 11, 2026
Daily AI digest
AI Retail Discussion Summary:
Galecto, a biopharmaceutical company, announced the pricing of a $275 million underwritten public offering of common stock.
Key Retail Themes:
Equity offering
Funding for Galecto's operations
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 2:05 PM ET
Data refreshes hourly during market hours. Next update: 3:05 PM
Data refreshes hourly during market hours. Next update: 3:05 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GLTO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 53 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 51 HOLD |
|
SNDX
Syndax Pharmaceuticals IâĻ |
STRONG BUY
12 analysts |
$35 | 60 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive GLTO Research Pages
